Han Myung-Hoon, Lee Eun-Hye, Koh Seong-Ho
Department of Neurosurgery, Hanyang University Guri Hospital, Guri, Korea.
Department of Neurology, Hanyang University College of Medicine, Seoul, Korea.
Int Neurourol J. 2016 Dec;20(4):276-287. doi: 10.5213/inj.1632776.388. Epub 2016 Dec 26.
Neurological diseases such as Alzheimer, Parkinson, and ischemic stroke have increased in occurrence and become important health issues throughout the world. There is currently no effective therapeutic strategy for addressing neurological deficits after the development of these major neurological disorders. In recent years, it has become accepted that adult neural stem cells located in the subventricular and subgranular zones have the ability to proliferate and differentiate in order to replace lost or damaged neural cells. There have been many limitations in the clinical application of both endogenous and exogenous neurogenesis for neurological disorders. However, many studies have investigated novel mechanisms in neurogenesis and have shown that these limitations can potentially be overcome with appropriate stimulation and various approaches. We will review concepts related to possible therapeutic strategies focused on the perspective of neurogenesis for the treatment of patients diagnosed with Alzheimer disease, Parkinson disease, and ischemic stroke based on current reports.
阿尔茨海默病、帕金森病和缺血性中风等神经疾病的发病率不断上升,已成为全球重要的健康问题。目前,对于这些主要神经疾病发生后出现的神经功能缺损,尚无有效的治疗策略。近年来,人们已经认识到,位于脑室下区和颗粒下区的成年神经干细胞具有增殖和分化的能力,以替代丢失或受损的神经细胞。内源性和外源性神经发生在神经疾病的临床应用中存在许多局限性。然而,许多研究已经对神经发生的新机制进行了研究,并表明通过适当的刺激和各种方法有可能克服这些局限性。我们将根据当前的报告,从神经发生的角度综述与治疗被诊断患有阿尔茨海默病、帕金森病和缺血性中风的患者的可能治疗策略相关的概念。